In a previous report of 138 COVID-19 inpatients from Wuhan, patients treated in ICU had higher levels of biomarkers (CK-MB and hs-cTnI) of myocardial injury than those do not need ICU care (Wang et al. 2020a). The gene discussed is TNNI3; the disease is COVID-19.